Thus, P7C3-mediated NAMPT activation is critical in ameliorating diabetic skeletal muscle phenotypes in mice, and the NAMPT activator P7C3 is a potential treatment strategy for type 2 diabetes that has yet to be tested in humans [81]. Here, NAMPT is linked to type 2 diabetes mellitus.